Processa Pharmaceuticals Stock Forecast - Naive Prediction

PCSA Stock  USD 1.16  0.18  18.37%   
The Naive Prediction forecasted value of Processa Pharmaceuticals on the next trading day is expected to be 1.29 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.56. Processa Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Processa Pharmaceuticals stock prices and determine the direction of Processa Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Processa Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Processa Pharmaceuticals' Receivables Turnover is projected to increase significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 1.46, whereas Inventory Turnover is forecasted to decline to 0.56. . As of November 30, 2024, Common Stock Shares Outstanding is expected to decline to about 1 M. The current year's Net Loss is expected to grow to about (9.8 M).

Processa Pharmaceuticals Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Processa Pharmaceuticals' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2012-09-30
Previous Quarter
5.6 M
Current Value
2.9 M
Quarterly Volatility
6.2 M
 
Yuan Drop
 
Covid
A naive forecasting model for Processa Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Processa Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Processa Pharmaceuticals Naive Prediction Price Forecast For the 1st of December

Given 90 days horizon, the Naive Prediction forecasted value of Processa Pharmaceuticals on the next trading day is expected to be 1.29 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.56.
Please note that although there have been many attempts to predict Processa Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Processa Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Processa Pharmaceuticals Stock Forecast Pattern

Backtest Processa PharmaceuticalsProcessa Pharmaceuticals Price PredictionBuy or Sell Advice 

Processa Pharmaceuticals Forecasted Value

In the context of forecasting Processa Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Processa Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 6.01, respectively. We have considered Processa Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.16
1.29
Expected Value
6.01
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Processa Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Processa Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.9317
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0413
MAPEMean absolute percentage error0.0345
SAESum of the absolute errors2.5603
This model is not at all useful as a medium-long range forecasting tool of Processa Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Processa Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Processa Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Processa Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.175.89
Details
Intrinsic
Valuation
LowRealHigh
0.081.616.33
Details
1 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details

Other Forecasting Options for Processa Pharmaceuticals

For every potential investor in Processa, whether a beginner or expert, Processa Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Processa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Processa. Basic forecasting techniques help filter out the noise by identifying Processa Pharmaceuticals' price trends.

View Processa Pharmaceuticals Related Equities

 Risk & Return  Correlation

Processa Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Processa Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Processa Pharmaceuticals' current price.

Processa Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Processa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Processa Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Processa Pharmaceuticals stock market strength indicators, traders can identify Processa Pharmaceuticals entry and exit signals to maximize returns.

Processa Pharmaceuticals Risk Indicators

The analysis of Processa Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Processa Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting processa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Processa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Processa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Processa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Processa Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Processa Pharmaceuticals to cross-verify your projections.
For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. If investors know Processa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Processa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.80)
Return On Assets
(1.13)
Return On Equity
(2.12)
The market value of Processa Pharmaceuticals is measured differently than its book value, which is the value of Processa that is recorded on the company's balance sheet. Investors also form their own opinion of Processa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Processa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Processa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Processa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Processa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Processa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Processa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.